机构：[1]Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology＆Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China首都医科大学附属北京同仁医院首都医科大学附属同仁医院
Chemotherapy remains an important approach for the treatment of liver metastases from uveal melanoma (UM). Compared with systemic chemotherapy, regional chemotherapy has similar efficacy and fewer systemic adverse effects. Regional chemotherapy for UM liver metastases includes hepatic artery infusion (HAI), transarterial chemoembolization (TACE), and isolated hepatic perfusion (IHP). In this review, we aim to examine the efficacy of regional chemotherapy and compare HAI, TACE, and IHP in terms of overall survival (OS). The three approaches showed no obvious difference in OS results.International Journal of Ophthalmology Press.
基金：
National Natural Science
Foundation of China (No.82141128); The Capital Health
Research and Development of Special (No.2020-1-2052);
Beijing Natural Science Foundation (No.7204245); Science
& Technology Project of Beijing Municipal Science
& Technology Commission (No.Z201100005520045;
No.Z181100001818003); Scientific Research Common
Program of Beijing Municipal Commission of Education (No.
KM202010025018); Beijing Municipal Administration of
Hospitals’ Youth Programme (No.QML20190202); Beijing
Dongcheng District Outstanding Talents Cultivating Plan
(No.2018).
第一作者机构：[1]Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology＆Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
共同第一作者：
通讯作者：
通讯机构：[1]Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology＆Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China[*1]Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology & Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
推荐引用方式(GB/T 7714)：
Tao Yang-Xu,Li Hao-Wen,Luo Jing-Ting,et al.Regional chemotherapy for uveal melanoma liver metastases[J].INTERNATIONAL JOURNAL OF OPHTHALMOLOGY.2023,16(2):293-300.doi:10.18240/ijo.2023.02.18.
APA：
Tao Yang-Xu,Li Hao-Wen,Luo Jing-Ting,Li Yang&Wei Wen-Bin.(2023).Regional chemotherapy for uveal melanoma liver metastases.INTERNATIONAL JOURNAL OF OPHTHALMOLOGY,16,(2)
MLA：
Tao Yang-Xu,et al."Regional chemotherapy for uveal melanoma liver metastases".INTERNATIONAL JOURNAL OF OPHTHALMOLOGY 16..2(2023):293-300
